Cargando…

Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India

BACKGROUND AND AIMS: During the current pandemic of COVID-19, India is under lockdown which could cause disruption in diet and lifestyle in patients with type 2 diabetes (T2DM). We aimed to study lifestyle changes and other common issues related to treatment in our previously seen and treated patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Amerta, Arora, Bhavya, Gupta, Ritesh, Anoop, Shajith, Misra, Anoop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265851/ https://www.ncbi.nlm.nih.gov/pubmed/32574982 http://dx.doi.org/10.1016/j.dsx.2020.05.044

Ejemplares similares

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020)

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Clinical considerations for patients with diabetes in times of COVID-19 epidemic
por: Gupta, Ritesh, et al.
Publicado: (2020)

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
por: Ghosh, Amerta, et al.
Publicado: (2020)

Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
por: Misra, Anoop, et al.
Publicado: (2021)

High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
por: Mittal, Juhi, et al.
Publicado: (2021)

Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India
por: Sabharwal, Mudit, et al.
Publicado: (2022)

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India
por: Gupta, Ritesh, et al.
Publicado: (2020)

COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes
por: Ghosh, Amerta, et al.
Publicado: (2020)

Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report
por: Ghosh, Amerta, et al.
Publicado: (2021)

Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study
por: Misra, Anoop, et al.
Publicado: (2015)

Correction: Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study
por: Misra, Anoop, et al.
Publicado: (2015)

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
por: Gupta, Ritesh, et al.
Publicado: (2020)

A randomized controlled trial to evaluate the effects of high Protein Complete (lActo) VEgetaRian (PACER) diet in non-diabetic obese Asian Indians in North India
por: Bhardwaj, Swati, et al.
Publicado: (2018)

High Plasma Glucagon Levels Correlate with Waist-to-Hip Ratio, Suprailiac Skinfold Thickness, and Deep Subcutaneous Abdominal and Intraperitoneal Adipose Tissue Depots in Nonobese Asian Indian Males with Type 2 Diabetes in North India
por: Anoop, Shajith, et al.
Publicado: (2017)

Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
por: Tyagi, Kanika, et al.
Publicado: (2021)

A Body shape index significantly predicts MRI-defined abdominal adipose tissue depots in non-obese Asian Indians with type 2 diabetes mellitus
por: Anoop, Shajith, et al.
Publicado: (2020)

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases
por: Mishra, Abha, et al.
Publicado: (2021)

SAT-650 Novel Insights into the Entero-Insular Axis in Fibrocalcific Pancreatic Diabetes: An Isoglycemic Intravenous Glucose Infusion (IIGI) Study from India
por: verma, shivendra, et al.
Publicado: (2020)

COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India
por: Gopalan, Hema S., et al.
Publicado: (2020)

COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research
por: Gupta, Ritesh, et al.
Publicado: (2020)

High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case–control study
por: Anoop, Shajith, et al.
Publicado: (2017)

Understanding the predictive accuracy of the InsuTAG index over other surrogate indices in normoglycaemic, non-obese males from Southern India
por: Jebasingh, Felix K., et al.
Publicado: (2023)

Diabetes and COVID-19: evidence, current status and unanswered research questions
por: Gupta, Ritesh, et al.
Publicado: (2020)

Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution
por: Misra, Anoop
Publicado: (2020)

Predictors for Gingival Index in Middle-Aged Asian Indians with Type 2 Diabetes from South India: A Cross-Sectional Observational Study
por: Karthik, S. Jai, et al.
Publicado: (2018)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Effect of Almond Supplementation on Glycemia and Cardiovascular Risk Factors in Asian Indians in North India with Type 2 Diabetes Mellitus: A 24–Week Study
por: Gulati, Seema, et al.
Publicado: (2017)

Lifestyle and behavioral changes during nationwide lockdown in India—A cross-sectional analysis
por: Singh, Vishwambhar, et al.
Publicado: (2021)

Sugar Intake, Obesity, and Diabetes in India
por: Gulati, Seema, et al.
Publicado: (2014)

Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India
por: Misra, Anoop
Publicado: (2021)

Infections and diabetes: Risks and mitigation with reference to India
por: Unnikrishnan, Ranjit, et al.
Publicado: (2020)

Recent trends in epidemiology of dyslipidemias in India
por: Gupta, Rajeev, et al.
Publicado: (2017)

Management of diabetes mellitus through teleconsultation during COVID-19 and similar scenarios - Guidelines from Indian Council of Medical Research (ICMR) expert group
por: Sarveswaran, Gokul, et al.
Publicado: (2021)

High Prevalence of Abdominal, Intra-Abdominal and Subcutaneous Adiposity and Clustering of Risk Factors among Urban Asian Indians in North India
por: Bhardwaj, Swati, et al.
Publicado: (2011)

Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Resurgence of COVID-19 and diabetes in India
por: Pal, Rimesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ludd8gu9ov189idlrl5fu9tub